Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Taking vitamin D and calcium supplements reduces the risk of hip fractures by about one sixth, but taking vitamin D alone does not, according to a new study from the Nuffield Department of Population Health (NDPH) at the University of Oxford.

None © Shutterstock

The research was led by Research Fellow Dr Pang Yao and Robert Clarke, Professor of Epidemiology and Public Health Medicine, at NDPH. The researchers combined findings from 11 observational studies of vitamin D blood levels and the associated risk of fracture with more than 39,000 participants, 6 trials of combined vitamin D and calcium treatment with more than 49,000 participants, and 11 trials of vitamin D supplements alone with 34,000 participants. The research has been published in JAMA Network Open.

The observational studies showed that low blood levels of vitamin D are associated with higher risks of fracture, but the trial results have been inconclusive. The trials of vitamin D plus calcium showed a small reduction in the risk of fractures. In people over the age of 80 years, and those living in institutions however, the effects were greater, with the risk of hip fracture lowered by almost one-third. While the trials of vitamin D alone did not show a reduction in the risk of fracture, these trials included some large studies of very high annual doses of vitamin D which increased the risk of fracture, and few of the trials tested doses of vitamin D high enough to raise the blood levels of vitamin D sufficiently to reduce the fracture risk.

Read more (University of Oxford)

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Biological processes of ageing is key to improving later life health

Improvements in health care, sanitation, and diet over last 100 years have significantly increased life expectancy. However, this increase in how long we can expect to live has not been accompanied by a similar increase in healthy life expectancy, defined as the time spent free of major illness or disease.